The leading representative office of defined VC is situated in the Beijing. The fund was located in Asia if to be more exact in China.
For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Refuge Biotechnologies. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the most popular fund investment industries, there are Therapeutics, Health Care.
The usual cause for the fund is to invest in rounds with 8 partakers. Despite the Ocean Pine Healthcare Fund, startups are often financed by WuXi Healthcare Ventures, Shangbay Capital, 3E Bioventures. The meaningful sponsors for the fund in investment in the same round are WuXi Healthcare Ventures, Shangbay Capital, Sequoia Capital China.
The fund is constantly included in less than 2 investment rounds annually. Deals in the range of 10 - 50 millions dollars are the general things for fund. The top activity for fund was in 2018.
Related Funds
Fund Name | Location |
235 Capital Partners | - |
50K Ventures | Andhra Pradesh, India, Madhapur |
Ader Finance | France, Ile-de-France, Paris |
Aquasourca | Luxembourg, Luxembourg |
Everbright Capital | China, Guangdong, Shenzhen |
Far East Organization | Central, Central Region, Singapore |
Foxcroft Enterprises, LLC | - |
Glass Wall Syndicate | - |
Hattery | California, San Francisco, United States |
Liberty Digital | California, Los Angeles, United States |
Lupa Systems | New York, New York, United States |
Midoriya Electric Co | - |
Noble Partners | - |
Pentland Ventures | England, London, United Kingdom |
Shanghai Industrial Holdings | China, Hong Kong, Hong Kong Island |
Synovus | Columbus, Georgia, United States |
The Small Exchange | Chicago, Illinois, United States |
Thomas Vickers Investment Group | - |
WAM LLC | Milwaukee, United States, Wisconsin |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Refuge Biotechnologies | $25M | 02 May 2018 | California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Refuge Biotechnologies | $25M | 02 May 2018 | California, United States |